Conventional medicine often falls short for chronic conditions. Learn how a different approach, one designed to work with your body's natural repair processes, is being studied as another option.
Standard medicine is built to handle acute problems: find the broken part and fix or suppress it. This works well for a broken bone or an infection. But for long-term conditions like arthritis, autoimmune disease, or neurological decline, it often falls short.
Pain medications can control symptoms but may speed up cartilage loss over time. Steroids reduce inflammation but can slow the tissue healing they are meant to protect. Surgery can repair or replace damaged structures, but it does not always address ongoing inflammation. For many chronic conditions, the underlying process continues.
Regenerative medicine takes a different approach. Instead of only managing symptoms, it aims to support your body's own repair processes. It is investigational, and results vary.
Regenerative medicine uses biological materials rather than synthetic drugs. It delivers cells, signaling particles, or growth factors, similar to those your body uses in repair, to the area being treated.
Your body already has a built-in repair system. It heals cuts, rebuilds broken bones, and clears out damaged cells. This system does not completely fail as you age. It just slows down. You have fewer stem cells, more inflammation, and slower healing signals over time.
Regenerative medicine is meant to work with your biology rather than override it. Stem cells, exosomes, and growth factors come from screened donor tissue, but they are the same kinds of biological tools your body uses in repair. Researchers are studying whether adding more of them, in the right place, can help with specific problems.
Each of these approaches is thought to support the body differently. They are sometimes combined, though whether that is appropriate is a decision for the treating physician, and results vary.
These cells release repair signals to surrounding cells and are studied for their ability to calm an overactive immune system. In the lab, they can also develop into several tissue types. They are the foundation of most protocols our partner physicians offer.
Exosomes are tiny particles released by stem cells. They carry signaling molecules that nearby cells can take up. Some patients notice changes sooner than with cell therapy, and researchers are studying them for inflammation and widespread conditions. Results vary.
These are concentrated growth factors from placenta tissue. They come from the same environment that helps build a baby's organs. They are used with the aim of supporting the body's repair activity after treatment.
Combination protocols layer stem cells, exosomes, and placenta extract. Whether combining modalities produces better outcomes than any one alone has not been established by controlled trials.
| Conventional | Regenerative | |
|---|---|---|
| Goal | Manage symptoms | Aim to support tissue function |
| Mechanism | Suppress or remove | Support the body's own repair |
| Duration | Ongoing (often indefinite) | Finite course; how long results last varies |
| Side effects | Often significant; systemic | Usually mild and short-lived; long-term data limited |
| Root cause | Rarely addressed | Aims at biological drivers (investigational) |
Not sure whether this applies to your case? Candidacy is determined by medical review of your history and imaging, not by a form. The consultation is complimentary.
See If You QualifyNot all regenerative clinics are the same. Cell count, cell quality, sourcing standards, and physician experience vary widely. These differences directly affect your results.
Look for these quality markers: verified cell counts, FDA-regulated donor screening, sterility testing, and physician oversight. At GSS, all cell preparations come from vetted suppliers with documented quality standards. Every treatment plan is designed by a physician, not a sales rep. Your consultation determines the right treatment, dose, and delivery method for your specific situation.
The treating provider reviews your medical history, imaging, and goals, and designs a treatment plan built for your specific condition, not a one-size-fits-all option.
The treating provider selects the right treatment type, dose, and delivery method based on how severe your condition is, your overall health, and your goals.
Most treatments are done on an outpatient basis the same day. We follow up at 4, 8, and 12 weeks to track your progress and adjust your plan if needed.
The broad idea is to support the body's own repair processes, whether through cells, signalling vesicles such as exosomes, or growth factor preparations. Mechanisms are better described in laboratory research than confirmed in human clinical outcomes.
Proteins that carry signals between cells, influencing processes such as inflammation and tissue repair. They are studied as part of several regenerative preparations.
No. Platelet-rich plasma is prepared from your own blood and concentrates platelets and growth factors. Cell-based therapies involve living cells, which is a different category of product with a different regulatory position.
This varies substantially between individuals, and some people report no meaningful change. Published timelines differ between studies and are not established, so any clinic quoting a confident number is going beyond the evidence.
Some cell-based products are FDA-approved for specific indications, mostly in blood and immune disorders. The applications discussed on this site are not among them, which is why they are described as investigational and performed in Mexico.
Let a licensed treating physician review your case and discuss whether a regenerative plan may be right for you. Request your consultation today.
See If You Qualify →